Revised “hPSC-Sac Method” for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2021-11-02

AUTHORS

Akinori Yuzuriha , Koji Eto

ABSTRACT

The human hematopoietic differentiation in vitro of human pluripotent stem cells (hPSCs) has provided new tools to elucidate the mechanisms of related genetic abnormalities, such as congenital diseases and acquired hematopoietic malignancies, and to discover new treatments. The differentiation can also be applied to developing a stable source of blood products for transfusion with minimal risk of several blood-borne infections. We previously proposed a method for hematopoietic progenitor cell (HPC) differentiation, the “hPSC-sac method”, in which hPSCs are cocultured with C3H10T1/2 mouse stromal cells and mixed with a single cytokine, VEGF. The hPSC-sac method can differentiate hPSCs to multiple blood lineages. Here we describe improvements in the method by adding bFGF, TGFβ inhibitor and heparin to the culture, which increases the yield of CD34+CD43+ HPCs 50-fold compared with the original protocol. This revised hPSC-sac method is expected to contribute to the development of disease models and regenerative medicine using hematopoietic lineage cells. More... »

PAGES

411-422

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/7651_2021_443

DOI

http://dx.doi.org/10.1007/7651_2021_443

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142328749

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34724185


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoiesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pluripotent Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuzuriha", 
        "givenName": "Akinori", 
        "id": "sg:person.01025210374.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025210374.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan", 
            "Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eto", 
        "givenName": "Koji", 
        "id": "sg:person.01062427654.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062427654.09"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2021-11-02", 
    "datePublishedReg": "2021-11-02", 
    "description": "The human hematopoietic differentiation in vitro of human pluripotent stem cells (hPSCs) has provided new tools to elucidate the mechanisms of related genetic abnormalities, such as congenital diseases and acquired hematopoietic malignancies, and to discover new treatments. The differentiation can also be applied to developing a stable source of blood products for transfusion with minimal risk of several blood-borne infections. We previously proposed a method for hematopoietic progenitor cell (HPC) differentiation, the \u201chPSC-sac method\u201d, in which hPSCs are cocultured with C3H10T1/2 mouse stromal cells and mixed with a single cytokine, VEGF. The hPSC-sac method can differentiate hPSCs to multiple blood lineages. Here we describe improvements in the method by adding bFGF, TGF\u03b2 inhibitor and heparin to the culture, which increases the yield of CD34+CD43+ HPCs 50-fold compared with the original protocol. This revised hPSC-sac method is expected to contribute to the development of disease models and regenerative medicine using hematopoietic lineage cells.", 
    "editor": [
      {
        "familyName": "Nagy", 
        "givenName": "Andras", 
        "type": "Person"
      }, 
      {
        "familyName": "Turksen", 
        "givenName": "Kursad", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/7651_2021_443", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-0716-2118-9", 
        "978-1-0716-2119-6"
      ], 
      "name": "Induced Pluripotent Stem (iPS) Cells", 
      "type": "Book"
    }, 
    "keywords": [
      "human pluripotent stem cells", 
      "pluripotent stem cells", 
      "hematopoietic progenitor cell differentiation", 
      "human hematopoietic differentiation", 
      "multiple blood lineages", 
      "stem cells", 
      "progenitor cell differentiation", 
      "hematopoietic lineage cells", 
      "mouse stromal cells", 
      "blood lineages", 
      "hematopoietic progenitor cells", 
      "hematopoietic differentiation", 
      "cell differentiation", 
      "efficient differentiation", 
      "lineage cells", 
      "progenitor cells", 
      "differentiation", 
      "regenerative medicine", 
      "stromal cells", 
      "hematopoietic malignancies", 
      "cells", 
      "genetic abnormalities", 
      "disease models", 
      "lineages", 
      "single cytokine", 
      "new tool", 
      "congenital disease", 
      "bFGF", 
      "inhibitors", 
      "VEGF", 
      "stable source", 
      "mechanism", 
      "cytokines", 
      "culture", 
      "yield", 
      "development", 
      "original protocol", 
      "infection", 
      "new treatments", 
      "disease", 
      "products", 
      "tool", 
      "abnormalities", 
      "source", 
      "malignancy", 
      "heparin", 
      "medicine", 
      "treatment", 
      "protocol", 
      "HPC", 
      "method", 
      "simple", 
      "model", 
      "minimal risk", 
      "risk", 
      "improvement", 
      "blood-borne infections", 
      "blood products", 
      "transfusion"
    ], 
    "name": "Revised \u201chPSC-Sac Method\u201d for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells", 
    "pagination": "411-422", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142328749"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/7651_2021_443"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34724185"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/7651_2021_443", 
      "https://app.dimensions.ai/details/publication/pub.1142328749"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_466.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/7651_2021_443"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/7651_2021_443'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/7651_2021_443'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/7651_2021_443'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/7651_2021_443'


 

This table displays all metadata directly associated to this object as RDF triples.

174 TRIPLES      22 PREDICATES      93 URIs      85 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/7651_2021_443 schema:about N51d947da603943b2ae13f8a221c67213
2 Na8ccdd7ec22e41e799fd3e4ed3755f32
3 Nc9f989152ade4858a7a4e6762455057d
4 Nde8bd72b36c84decb23cb9fda2591fb9
5 Ne457967e3f9b44cfab804dde41ea76e4
6 Neb4b0511077241f1a404d6407fd64438
7 Nf9f396b58c6d4314b6cdf1575b95b5d0
8 Nfc6649dd347c475dbf5a235e53cac1c2
9 anzsrc-for:06
10 anzsrc-for:0601
11 anzsrc-for:0604
12 schema:author Nb7e98a5c44e3428196c2b7e4699883cf
13 schema:datePublished 2021-11-02
14 schema:datePublishedReg 2021-11-02
15 schema:description The human hematopoietic differentiation in vitro of human pluripotent stem cells (hPSCs) has provided new tools to elucidate the mechanisms of related genetic abnormalities, such as congenital diseases and acquired hematopoietic malignancies, and to discover new treatments. The differentiation can also be applied to developing a stable source of blood products for transfusion with minimal risk of several blood-borne infections. We previously proposed a method for hematopoietic progenitor cell (HPC) differentiation, the “hPSC-sac method”, in which hPSCs are cocultured with C3H10T1/2 mouse stromal cells and mixed with a single cytokine, VEGF. The hPSC-sac method can differentiate hPSCs to multiple blood lineages. Here we describe improvements in the method by adding bFGF, TGFβ inhibitor and heparin to the culture, which increases the yield of CD34+CD43+ HPCs 50-fold compared with the original protocol. This revised hPSC-sac method is expected to contribute to the development of disease models and regenerative medicine using hematopoietic lineage cells.
16 schema:editor Ndc5299b295f04f6dac66967cd5be48d5
17 schema:genre chapter
18 schema:isAccessibleForFree false
19 schema:isPartOf N69e1df8764824111a604b6dba6979303
20 schema:keywords HPC
21 VEGF
22 abnormalities
23 bFGF
24 blood lineages
25 blood products
26 blood-borne infections
27 cell differentiation
28 cells
29 congenital disease
30 culture
31 cytokines
32 development
33 differentiation
34 disease
35 disease models
36 efficient differentiation
37 genetic abnormalities
38 hematopoietic differentiation
39 hematopoietic lineage cells
40 hematopoietic malignancies
41 hematopoietic progenitor cell differentiation
42 hematopoietic progenitor cells
43 heparin
44 human hematopoietic differentiation
45 human pluripotent stem cells
46 improvement
47 infection
48 inhibitors
49 lineage cells
50 lineages
51 malignancy
52 mechanism
53 medicine
54 method
55 minimal risk
56 model
57 mouse stromal cells
58 multiple blood lineages
59 new tool
60 new treatments
61 original protocol
62 pluripotent stem cells
63 products
64 progenitor cell differentiation
65 progenitor cells
66 protocol
67 regenerative medicine
68 risk
69 simple
70 single cytokine
71 source
72 stable source
73 stem cells
74 stromal cells
75 tool
76 transfusion
77 treatment
78 yield
79 schema:name Revised “hPSC-Sac Method” for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells
80 schema:pagination 411-422
81 schema:productId N9239fcbdde2f4d66aa644427125a4a21
82 Nb4c4f00d72a14562a88794560f520f9d
83 Nf5fb1ad33bc74d2c98ec333f1496ef6d
84 schema:publisher N944f5b2e8a8b4bbeaef192ce34175f1e
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142328749
86 https://doi.org/10.1007/7651_2021_443
87 schema:sdDatePublished 2022-09-02T16:17
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N13add7e7b0e94eb1906b30637ff30663
90 schema:url https://doi.org/10.1007/7651_2021_443
91 sgo:license sg:explorer/license/
92 sgo:sdDataset chapters
93 rdf:type schema:Chapter
94 N13add7e7b0e94eb1906b30637ff30663 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N2112621221b540d7bedc80f67a7dcd14 rdf:first sg:person.01062427654.09
97 rdf:rest rdf:nil
98 N51d947da603943b2ae13f8a221c67213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Transforming Growth Factor beta
100 rdf:type schema:DefinedTerm
101 N5c3c1ec222294b9abc1e352247822a3d schema:familyName Nagy
102 schema:givenName Andras
103 rdf:type schema:Person
104 N69e1df8764824111a604b6dba6979303 schema:isbn 978-1-0716-2118-9
105 978-1-0716-2119-6
106 schema:name Induced Pluripotent Stem (iPS) Cells
107 rdf:type schema:Book
108 N9239fcbdde2f4d66aa644427125a4a21 schema:name doi
109 schema:value 10.1007/7651_2021_443
110 rdf:type schema:PropertyValue
111 N944f5b2e8a8b4bbeaef192ce34175f1e schema:name Springer Nature
112 rdf:type schema:Organisation
113 Na11dc08609d34425a7cdf3dd58c9e655 schema:familyName Turksen
114 schema:givenName Kursad
115 rdf:type schema:Person
116 Na8ccdd7ec22e41e799fd3e4ed3755f32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 Nb4c4f00d72a14562a88794560f520f9d schema:name pubmed_id
120 schema:value 34724185
121 rdf:type schema:PropertyValue
122 Nb7e98a5c44e3428196c2b7e4699883cf rdf:first sg:person.01025210374.82
123 rdf:rest N2112621221b540d7bedc80f67a7dcd14
124 Nbbb6ae2baf274f38b7f382851adc22e5 rdf:first Na11dc08609d34425a7cdf3dd58c9e655
125 rdf:rest rdf:nil
126 Nc9f989152ade4858a7a4e6762455057d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Mice
128 rdf:type schema:DefinedTerm
129 Ndc5299b295f04f6dac66967cd5be48d5 rdf:first N5c3c1ec222294b9abc1e352247822a3d
130 rdf:rest Nbbb6ae2baf274f38b7f382851adc22e5
131 Nde8bd72b36c84decb23cb9fda2591fb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Pluripotent Stem Cells
133 rdf:type schema:DefinedTerm
134 Ne457967e3f9b44cfab804dde41ea76e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Cell Differentiation
136 rdf:type schema:DefinedTerm
137 Neb4b0511077241f1a404d6407fd64438 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Hematopoietic Stem Cells
139 rdf:type schema:DefinedTerm
140 Nf5fb1ad33bc74d2c98ec333f1496ef6d schema:name dimensions_id
141 schema:value pub.1142328749
142 rdf:type schema:PropertyValue
143 Nf9f396b58c6d4314b6cdf1575b95b5d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Animals
145 rdf:type schema:DefinedTerm
146 Nfc6649dd347c475dbf5a235e53cac1c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Hematopoiesis
148 rdf:type schema:DefinedTerm
149 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
150 schema:name Biological Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
153 schema:name Biochemistry and Cell Biology
154 rdf:type schema:DefinedTerm
155 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
156 schema:name Genetics
157 rdf:type schema:DefinedTerm
158 sg:person.01025210374.82 schema:affiliation grid-institutes:grid.258799.8
159 schema:familyName Yuzuriha
160 schema:givenName Akinori
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025210374.82
162 rdf:type schema:Person
163 sg:person.01062427654.09 schema:affiliation grid-institutes:grid.136304.3
164 schema:familyName Eto
165 schema:givenName Koji
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062427654.09
167 rdf:type schema:Person
168 grid-institutes:grid.136304.3 schema:alternateName Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
169 schema:name Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan
170 Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
171 rdf:type schema:Organization
172 grid-institutes:grid.258799.8 schema:alternateName Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan
173 schema:name Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan
174 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...